Diabetes Clinical Trials

Showing 7781-7800 of 7,874 trials

Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes

NCT00110864

This study is designed to evaluate the safety and efficacy of PN2034 in insulin-dependent type 2 diabetics as measured by the change in average daily insulin dose from baseline to week 12. The effects of PN2034 on HbA1c, fasting plasma glucose (FPG), and lipid levels will also be measured.

Type 2 Diabetes Mellitus

Wellstat Therapeutics90 participantsStarted May 2005

Waterbury, Connecticut, United States • Hollywood, Florida, United States • Longwood, Florida, United States +15 more locations

COMPLETEDPhase 2

Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

NCT00110851

This study is designed to evaluate the safety and efficacy of PN2034 administered to type 2 diabetics on concomitant rosiglitazone and metformin (or Avandamet) therapy as measured by change in glycosylated hemoglobin (HbA1c) levels from baseline to Week 12. Also the study will evaluate the effect of PN2034 on glucose control as measured by fasting plasma glucose (FPG) and on fasting lipid levels: triglycerides, total cholesterol, high-density lipoproteins (HDL), low-density lipoproteins (LDL), and very low-density lipoproteins (VLDL).

Type 2 Diabetes Mellitus

Wellstat Therapeutics90 participantsStarted Apr 2005

Waterbury, Connecticut, United States • DeLand, Florida, United States • Hollywood, Florida, United States +17 more locations

Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes

Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

Related Searches

Exercise Training in Older Diabetic Women

Lyspro Insulin vs Regular Insulin in Cirrhotic Patients

Determining the Effect on Patients of Internet-Based Diabetes Disease Management

Effect of Adiponectin Genetic Polymorphism on Rosiglitazone Response

Testing Ascensia Contour Glucometer for the Measurement of Blood Glucose

Lifestyle Intervention in Primary Health Care - the Björknäs Study

Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study

To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 Diabetes

The Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.

Comparison Between Pioglitazone and SES With type2 DM

Anodyne Therapy in Diabetic Sensory Neuropathy

Impact of Optimized Titration and Delivery of Bedtime Insulin on Prevention of Nocturnal Hypoglycemia

The Effects of Exercise on Adipokine in Impaired Fasting Glucose or Impaired Glucose Tolerance Patients

Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy

Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 Diabetes

Diabetes Quality Improvement Program on Diabetes Case Management Program 2001

Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease

Sub-Cutaneous Insulin in Hyperglycaemic Emergencies